HOME >> MEDICINE >> NEWS
Patients with disease, cancer of the esophagus benefit from new technique developed by OHSU surgeons

PORTLAND, Ore. - Surgeons at the Oregon Health & Science University Digestive Health Center have developed a new technique that makes feasible and safe a potentially lifesaving and noninvasive surgical procedure known as laparoscopic esophagectomy. Until now, the procedure was considered too technically demanding for most surgeons to perform. A paper on their findings recently was presented at the European Association of Endoscopic Surgery in Venice, Italy.

For more than a decade, the original procedure has been used in a few specialized centers around the world to remove cancer as well as other diseased tissue of the esophagus laparoscopically, that is by inserting fiber-optic instruments into a small, quarter-sized incision in the abdomen and maneuvering them to the affected portion of the esophagus while observing with a camera.

When first introduced, the less invasive laparoscopic esophagectomy was embraced by surgeons eager to forgo traditional open surgery, which requires cutting through the patient's chest. But it proved so difficult and time-consuming that most surgeons abandoned it, according to John G. Hunter, M.D., co-director of the OHSU Digestive Health Center, chairman of surgery in the OHSU School of Medicine, and co-author of the paper.

Hunter, a pioneer in minimally invasive surgery, however, did not abandon it. He knew from experience that laparoscopic surgery is inherently better for patients. "They recover faster with less pain, fewer complications and smaller scars," he explained.

He and colleagues worked in earnest to develop a means by which they could more easily and safely perform laparoscopic esophagectomies. The fruit of that labor is the laparoscopic inversion esophagectomy, or LIE. The LIE eliminates some of the technical obstacles that plagued the original procedure, the researchers report.

"With the original laparoscopic esophagectomy, the entire esophagus is in the way as you try to take it out
'"/>

Contact: Tamara Hargens
hargenst@ohsu.edu
503 494-8231
Oregon Health & Science University
9-Jun-2005


Page: 1 2 3

Related medicine news :

1. Patients with soft tissue sarcomas should be treated at high volume centers
2. Patients with bleeding strokes less likely to get prevention treatment
3. Patients should be alert for obesity surgery complication
4. Patients with type 1 diabetes dont wake in response to hypoglycemia
5. Cancer Patients Nationwide Can More Easily Navigate Health Care System
6. Patients with PTSD experience less pain sensitivity -- may be related to altered processing
7. Patients requests for antidepressants can influence physician evaluation of depression
8. Patients unaware of risks and purpose of research even after informed consent
9. Patients can report statins adverse effects on new web site
10. National study: Patients poorly prepared for end-of-life decisions
11. Patients receiving treatment with radioisotopes may trigger security alarms

Post Your Comments:
(Date:6/18/2013)... June 18, 2013 David Connett, DO, ... Family Medicine for the College of Osteopathic Medicine of ... has been elected president of the Osteopathic Medical ... Brown Jr. appointed Connett, a 1984 alumnus of COMP, ... recently elected Connett to the position during a conference ...
(Date:6/18/2013)... N.Y., June 18, 2013 -- Lauren Sciences, a ... V-Smart nanovesicle platform technology, announced today that it ... Drug Delivery with its V-Smart Platform, and selected ... by MCD Group. , The report, ... Start-ups and Emerging Companies ," features companies MCD ...
(Date:6/18/2013)... enrolled their first patients in the ROADSTER Study, a ... to help clear blockages in carotid arteries and prevent ... in the United States are diagnosed with blockages, or ... blockages can slow or even stop blood flow to ... as a "brain attack." , Current treatment options ...
(Date:6/18/2013)... scrambling to gather data for the FDA to support ... injury in the United States. The University of Rochester ... the Journal of Neurotrauma that it might ... of one., Jeffrey J. Bazarian, M.D., M.P.H., an associate ... first to show that measuring a combination of two ...
(Date:6/18/2013)... system using a person,s DNA was announced as ... London Startup Competition, Europe,s largest technology conference. ... on University of Bristol research by its founders, ... Professor of Bioinformatics in the University,s Department of ... to be one of 16 finalists in the ...
Breaking Medicine News(10 mins):Health News:UH Case Medical Center among first to enroll patients for global carotid artery trial 2
(Date:6/18/2013)... 18, 2013  Cataracts are the leading cause of ... of Ophthalmology, aging is the leading cause of eye ... natural lens. 22 million Americans age 40 and older ... to age, that number will increase over 30 million. ... iPads, smart-phones and computers, the demographic of ages 40 ...
(Date:6/18/2013)... , June 18, 2013  Decision Resources, ... firms for pharmaceutical and healthcare issues, announces that ... of the Middle East ... Tracker analyzes the challenges and opportunities to gaining ... international regions comprising 24 countries. The countries covered ...
(Date:6/18/2013)... NEW YORK , June 18, 2013 ... Gilead Sciences, Inc. (NASDAQ: GILD ), Health Management ... (NASDAQ: IDXX ), ISIS Pharmaceuticals Inc. (NASDAQ: ... readers may access these reports free of charge - including ... the links below. Gilead Sciences, Inc. Research Report ...
Breaking Medicine Technology:New Vision Hope For Millions Undergoing Cataract Surgery 2New Vision Hope For Millions Undergoing Cataract Surgery 3Decision Resources' Market Access Tracker Now Covers the Middle East and Africa 2Decision Resources' Market Access Tracker Now Covers the Middle East and Africa 3Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 2Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 3Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 4Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 5Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 6
Cached News: